Ticker Information
Ticker
TEVACompany Name
TEVA PHARMACEUTICAL INDUSTRIES LTDSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NYSE5.7%Research and Development Margin
VS
Market
29
Sector
74
Industry
57
History
90
$ 34.52Close
$ 15.38 - $ 36.3452-Week Range
TEVA PHARMACEUTICAL INDUSTRIES LTD - Research and Development Margin Chart Analysis (TTM)
Date Range
Zoom
TEVA - Research and Development Margin Historical Data
| Date | Revenues | Research and Development Expense | Research and Development Margin |
|---|---|---|---|
| 2026-03-31 | $ 17.35B | $ 989M | 5.7% |
| 2025-12-31 | $ 17.26B | $ 1.01B | 5.87% |
| 2025-09-30 | $ 16.78B | $ 994M | 5.93% |
| 2025-06-30 | $ 16.63B | $ 978M | 5.88% |
| 2025-03-31 | $ 16.62B | $ 1B | 6.04% |
| 2024-12-31 | $ 16.54B | $ 998M | 6.03% |
| 2024-09-30 | $ 16.77B | $ 978M | 5.83% |
| 2024-06-30 | $ 16.29B | $ 991M | 6.08% |
| 2024-03-31 | $ 16B | $ 962M | 6.01% |
| 2023-12-31 | $ 15.85B | $ 953M | 6.01% |
Key Performance Insights, Last 5 Years
- ✓ TEVA PHARMACEUTICAL INDUSTRIES LTD's latest trailing twelve months (TTM) R&D % stands at 5.7%.
- ✓ Over the past 5 years, TEVA PHARMACEUTICAL INDUSTRIES LTD's average R&D % has been 5.95%.
- ✓ The median R&D % for TEVA PHARMACEUTICAL INDUSTRIES LTD during this period was 5.98%
- ✓ TEVA PHARMACEUTICAL INDUSTRIES LTD reached its highest R&D % over the past 5 years at 6.45%.
- ✓ The lowest R&D % recorded by TEVA PHARMACEUTICAL INDUSTRIES LTD in the same timeframe 5.61%
TEVA PHARMACEUTICAL INDUSTRIES LTD's R&D % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
R&D % Benchmarks
| Company | R&D % |
|---|---|
| ZTS : ZOETIS INC | 7.58% |
| VTRS : VIATRIS INC | 6.82% |
| BDX : BECTON DICKINSON & CO | 5.49% |
| IQV : IQVIA HOLDINGS INC | 0% |
| GEHC : GE HEALTHCARE TECHNOLOGIES INC | 6.02% |
| LH : LABCORP HOLDINGS INC | 0% |
| BIIB : BIOGEN INC | 18.95% |
| BHC : BAUSCH HEALTH COMPANIES INC | 6.16% |
| ALNY : ALNYLAM PHARMACEUTICALS INC | 33.11% |
| UHS : UNIVERSAL HEALTH SERVICES INC | 0% |
Similar metrics to R&D %:
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
- Research and Development Expense - [Income Statement] Research and development (R&D) expenses are direct costs relating to a company's efforts to develop and improve its goods or services. R&D is a component of Operating Expenses [OpEx].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
Definition of Research and Development Margin
[Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
R&D / Revenues
(=) R&D %R&D % for TEVA PHARMACEUTICAL INDUSTRIES LTD is calculated as follows:
R&D [ $ 989M ] / Revenues [ $ 17.35B ]
(=) R&D % [ 5.7% ] TEVA - Research and Development Margin, Last 5 years
5.61%
Minimum
Dec 31, 2022
6.45%
Maximum
Jun 30, 2021
5.95%
Average
5.98%
Median
R&D % Benchmark AnalysisMarket
The chart above depicts the distribution of R&D % for companies in the Total Stock Market. The average R&D % of the companies is 639.2% with a standard deviation of 14228.13%.
The following table provides additional summary stats:
R&D % in the Market:
| filtered constituents | 3.79K |
|---|---|
| min | -1111.11% |
| max | 651400% |
| average | 639.2% |
| median | 0% |
| std | 14228.13% |